Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
A Diagnostic Journey through a Rare Hemostatic Disorder.
Journal: The journal of applied laboratory medicine
Published: August 21, 2025
The clot cases conference: a proposed model to enhance multidisciplinary thrombosis care.
Journal: Journal of thrombosis and thrombolysis
Published: May 12, 2025
Determination of Fibrinogen Ratio Cutoff Limits Using Indirect Reference Interval Methodology.
Journal: International journal of laboratory hematology
Published: April 02, 2025
The FDA's proposed rule on laboratory-developed tests: what happens next?
Journal: Laboratory medicine
Published: February 19, 2024
Automation of a Factor XIII Activity Assay Utilizing a Plasma Blank Measurement.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 19, 2023
Assessment for Learning with Ungraded and Graded Assessments.
Journal: Medical science educator
Published: August 25, 2022
Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT.
Journal: Blood advances
Published: April 01, 2022
Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
Journal: American journal of hematology
Published: January 27, 2022
Cryptogenic oozers and bruisers.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 10, 2021
Direct oral anticoagulant (DOAC) interference in hemostasis assays.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 10, 2021
Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT.
Journal: Blood
Published: October 26, 2021
Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin.
Journal: medRxiv : the preprint server for health sciences
Published: October 06, 2021
Last Updated: 09/26/2026